tirzepatide cv outcomes trial Original Article: Cardiovascular with in Type 2 Diabetes (SURPASS-CVOT) A comparison of the effects

Track your consumption honestly If you are reducing but not eliminating alcohol, track what you actually drink versus what you think you drink

What strategies do you recommend to reduce the risk of rebound weight gain if I stop the drug

Alcohol can affect your blood sugar levels and add extra calories, which may work against your weight loss goals

What the research shows In the SURMOUNT-1 trial, adults taking once-weekly tirzepatide lost an average of about 15% to 21% of their body weight over 72 weeks depending on dose

By reducing appetite and slowing digestion, it helps some people lose a significant amount of weight

Increasing the mg dose in increments to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and a maximum of 15 mg